Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care Facilities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04377165
Recruitment Status : Terminated (Engagement issues, poor recruitment to study)
First Posted : May 6, 2020
Last Update Posted : September 4, 2020
Sponsor:
Information provided by (Responsible Party):
The University of Queensland

Brief Summary:
This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. There are 2 groups in this trial on group will receive current and accurate information from an app. The other group will receives the app with the addition of a gamification competent, this will include rewarding experiences for staff doing safety behaviours and wellbeing behaviours. The purpose of the gamification is to create a calming and reassuring experience that injects positivity and joy where possible during this stressful time.

Condition or disease Intervention/treatment Phase
COVID Influenza Gastroenteritis Behavioral: Gamification Behavioral: Newsfeed function Not Applicable

Detailed Description:

The study design will be a multi- centre cluster randomised control trial, where Age Care facilities are randomised into two groups:

  1. Newsfeed- gets the app with newsfeed only
  2. Gamification group- gets the full gamified app, including the newsfeed Workers in our network of residential aged care facilities will be invited to participate in a study of communication of information regarding COVID-19 and how they will play a role in preventing its spread.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care
Actual Study Start Date : May 6, 2020
Actual Primary Completion Date : August 26, 2020
Actual Study Completion Date : August 26, 2020

Arm Intervention/treatment
Active Comparator: Newsfeed
This will provide you with reliable accurate information on the pandemic.
Behavioral: Newsfeed function
This will provide the user with reliable accurate information on the pandemic.

Experimental: Gamification
The gamification function will allow users to earn points for actions completed. The gamification function has links to resources for infection control, watching or completing tasks or playing games to earn points. Points can be viewed at a facility level, state level or national level.
Behavioral: Gamification
This will provide the user with the newsfeed function and the addition of a gamification function




Primary Outcome Measures :
  1. To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group [ Time Frame: 4 weeks ]
    Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms


Secondary Outcome Measures :
  1. To compare handwashing behaviour [ Time Frame: 4 weeks ]
    Compare the amount of soap/sanitiser used between the arms

  2. To compare self-testing rates [ Time Frame: 4 weeks ]
    Compare the number of self tests between the two arms

  3. To compare the level of surface wipe down [ Time Frame: 4 weeks ]
    Compare the amount of wipes/disinfectant used between the two arms

  4. To compare number of COVID-19 tests completed in Facilities [ Time Frame: 4 weeks ]
    Compare the number of COVID-19 tests between the two arms

  5. To compare the number of COVID 19 infections in facilities [ Time Frame: 4 weeks ]
    Compare the number of COVID-19 infections between the arms

  6. To compare the other types of outbreaks (Flu, gastroenteritis) [ Time Frame: 4 weeks ]
    Compare the number of flu and gastroenteritis outbreaks between the arms

  7. To compare the awareness of COVID 19 training available to workers in the facilities [ Time Frame: 4 weeks ]
    Compare the COVID 19 training between the two arms, this is via a self reported survey

  8. To compare the awareness of PPE training available to workers in the facilities [ Time Frame: 4 weeks ]
    Compare the awareness of PPE training of the workers in the two arms, this is captured in self reported survey

  9. To compare the levels of PPE material used in [ Time Frame: 4 weeks ]
    Compare the amount of PPE used between the arms

  10. To compare the wellbeing and self-efficacy of the two groups [ Time Frame: 4 weeks ]
    Compare the wellbeing and self-efficacy between the two arms, this is captured in a self reported survey.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age Health Care Worker

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04377165


Sponsors and Collaborators
The University of Queensland
Investigators
Layout table for investigator information
Principal Investigator: David L Paterson, PhD The University of Queensland
Layout table for additonal information
Responsible Party: The University of Queensland
ClinicalTrials.gov Identifier: NCT04377165    
Other Study ID Numbers: Care Collective Study
First Posted: May 6, 2020    Key Record Dates
Last Update Posted: September 4, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by The University of Queensland:
Infection Control
Additional relevant MeSH terms:
Layout table for MeSH terms
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases